These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 182445)

  • 21. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread.
    Amundsen AL; Ntanios F; Put Nv; Ose L
    Eur J Clin Nutr; 2004 Dec; 58(12):1612-20. PubMed ID: 15199384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ileal exclusion on lipoprotein sitosterol in familial hypercholesterolaemia.
    Koivisto PV; Miettinen TA
    Scand J Clin Lab Invest; 1988 Apr; 48(2):193-8. PubMed ID: 3358098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein changes in familial hypercholesterolemia after extracorporeal immunoadsorption of low density lipoproteins.
    Riesen WF; Jaross W; Descoeudres C; Mordasini R; Koban F; Thulin H; Fisher S; Bergmann S
    Ann Biol Clin (Paris); 1988; 46(10):787-91. PubMed ID: 3232868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.
    Schneider J; Müller R; Buberl W; Kaffarnik H; Schubotz R; Hausmann L; Mühlfellner G; Mühlfellner O
    Eur J Clin Pharmacol; 1979 Feb; 15(1):15-9. PubMed ID: 217694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined para-aminosalicylic acid and dietary therapy in long-term control of hypercholesterolemia and hypertriglyceridemia (Types IIa and IIb hyperlipoproteinemia).
    Kuo PT; Fan WC; Kostis JB; Hayase K
    Circulation; 1976 Feb; 53(2):338-41. PubMed ID: 173477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inheritance of mild Type II hyperlipoproteinaemia.
    Ballantyne D; Lawrie TD
    Scott Med J; 1975 Jan; 20(1):23-6. PubMed ID: 163035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Studies in patients with types II-A and II-B.
    Barter PJ; Connor WE; Spector AA; Armstrong M; Connor SL; Newman MA
    Ann Intern Med; 1974 Nov; 81(5):619-24. PubMed ID: 4609028
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagné C; Lupien P; Tétreault L
    Clin Pharmacol Ther; 1975 May; 17(5):606-11. PubMed ID: 165029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowering plasma cholesterol with beta-sitosterol and diet.
    Drexel H; Breier C; Lisch HJ; Sailer S
    Lancet; 1981 May; 1(8230):1157. PubMed ID: 6112507
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic failure in familial type II hyperlipoproteinemia.
    Witters LA; Herbert PN; Shulman RS; Krauss RM; Levy RI
    Metabolism; 1976 Sep; 25(9):1017-26. PubMed ID: 183084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of D-thyroxine on the metabolism of cholesterol in familial hyperbetalipoproteinaemia.
    Simons LA; Myant NB
    Atherosclerosis; 1974; 19(1):103-17. PubMed ID: 4359180
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of type II hyperlipoproteinemia--personal experiences].
    Sznajderman M
    Pol Arch Med Wewn; 1978 Feb; 59(2):153-60. PubMed ID: 205843
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of the effects of cholestyramine and neomycin in the treatment of type II hyperlipoproteinaemia.
    Schade RW; van't Laar A; Majoor CL; Jansen AP
    Acta Med Scand; 1976; 199(3):175-80. PubMed ID: 176876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tolerance of beta-sitosterin from Hypoxis rooperi in patients with limited liver function. Results of a controlled double-blind study].
    Bräuer H; Schomann C
    Fortschr Med; 1978 Apr; 96(15):833-4. PubMed ID: 565318
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of sitosterol administration upon the serum cholesterol level and lipoprotein pattern.
    JOYNER C; KUO PT
    Am J Med Sci; 1955 Dec; 230(6):636-47. PubMed ID: 13268442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of a double-blind study on the effectiveness of a drug for conservative treatment of prostatic adenoma].
    Ebbinghaus KD; Baur MP
    ZFA (Stuttgart); 1977 Jun; 53(18):1054-8. PubMed ID: 70119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.